"Arginine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential amino acid that is physiologically active in the L-form.
Descriptor ID |
D001120
|
MeSH Number(s) |
D12.125.068.050 D12.125.095.104 D12.125.142.087
|
Concept/Terms |
Arginine- Arginine
- L-Arginine
- L Arginine
- Arginine, L-Isomer
- Arginine, L Isomer
- L-Isomer Arginine
|
Below are MeSH descriptors whose meaning is more general than "Arginine".
Below are MeSH descriptors whose meaning is more specific than "Arginine".
This graph shows the total number of publications written about "Arginine" by people in this website by year, and whether "Arginine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 3 | 5 |
1995 | 2 | 7 | 9 |
1996 | 3 | 4 | 7 |
1997 | 0 | 3 | 3 |
1998 | 2 | 3 | 5 |
1999 | 3 | 0 | 3 |
2000 | 2 | 4 | 6 |
2001 | 1 | 3 | 4 |
2002 | 2 | 1 | 3 |
2003 | 4 | 6 | 10 |
2004 | 4 | 8 | 12 |
2005 | 2 | 13 | 15 |
2006 | 4 | 4 | 8 |
2007 | 6 | 7 | 13 |
2008 | 2 | 4 | 6 |
2009 | 6 | 6 | 12 |
2010 | 13 | 7 | 20 |
2011 | 1 | 6 | 7 |
2012 | 10 | 7 | 17 |
2013 | 6 | 7 | 13 |
2014 | 2 | 6 | 8 |
2015 | 12 | 4 | 16 |
2016 | 9 | 6 | 15 |
2017 | 7 | 7 | 14 |
2018 | 5 | 8 | 13 |
2019 | 7 | 7 | 14 |
2020 | 3 | 5 | 8 |
2021 | 1 | 7 | 8 |
2022 | 1 | 2 | 3 |
2023 | 0 | 10 | 10 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arginine" by people in Profiles.
-
Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nat Commun. 2024 Mar 19; 15(1):2461.
-
PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. Cell Rep Med. 2023 12 19; 4(12):101326.
-
Nitric oxide is required for lung alveolarization revealed by deficiency of argininosuccinate lyase. Hum Mol Genet. 2023 Dec 12; 33(1):33-37.
-
Impact of supplementation with L-citrulline/arginine after liver transplantation in individuals with Urea Cycle Disorders. Mol Genet Metab. 2024 Mar; 141(3):108112.
-
Heteroplasmic pathogenic m.12315G>A variant in MT-TL2 presenting with MELAS syndrome and depletion of nitric oxide donors. Am J Med Genet A. 2024 Mar; 194(3):e63461.
-
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality. Am J Physiol Gastrointest Liver Physiol. 2023 11 01; 325(5):G471-G491.
-
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. Trials. 2023 Aug 17; 24(1):538.
-
Dimethylarginine Dimethylaminohydrolase - 1 expression is increased under tBHP-induced oxidative stress regulates nitric oxide production in PCa cells attenuates mitochondrial ROS-mediated apoptosis. Nitric Oxide. 2023 09 01; 138-139:70-84.
-
Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
-
Combined immunodeficiency caused by pathogenic variants in the ZAP70 C-terminal SH2 domain. Front Immunol. 2023; 14:1155883.